Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1669432

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that (a) new clinical trials have the support they need to recruit patients and (b) patients are made aware of clinical trials as a potential way to access new medicines.
tabling member constituency	Alyn and Deeside
tabling member printed	Mark Tami
uin	1458
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The Department funds research through the National Institute for Health and Care Research (NIHR). NIHR invests in expertise, specialist facilities, a research delivery workforce and support services to support recruitment to clinical trials. The NIHR Clinical Research Facilities support the delivery of early phase trials and the NIHR Clinical Research Network (CRN) and Patient Recruitment Centres support delivery and participation in later phase clinical trials.</p><p>The NIHR also provides the online platform 'Be Part of Research' which allow users to search for and register interest in clinical trials, matching people to trials of relevance to them.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:23:48 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1383 label Biography information for Mark Tami

1669465

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgical Hubs: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department plans to take to ensure surgical hubs are fully-staffed with (a) allied health professionals and (b) other staff.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	1587
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>Action is being taken to increase and support the existing NHS workforce capacity. The Getting it Right First Time (GIRFT) surgical hub programme has published workforce guidance designed to assist providers and integrated care systems (ICSs) in planning the workforce requirements for new or expanded surgical hubs. The guidance outlines key enablers for successful workforce recruitment, retention and planning, as well as helpful operational tools such as e-rostering and staff passports. The guidance focuses on surgical and theatre teams as well as on the wider hub team including allied health professionals.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:28:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4368 label Biography information for Neil Coyle

1669474

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve the five-year survival rate for people with pulmonary fibrosis.
tabling member constituency	Liverpool, West Derby
tabling member printed	Ian Byrne
uin	1727
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>Patients with pulmonary fibrosis are cared for by National Health Service regional specialist Interstitial lung disease services. These are commissioned by NHS England. In order to be referred to a specialist service patients need to be identified in primary and secondary care. Early and accurate diagnosis is a priority for NHS England, and the work to improve this area of clinical care is underway, which should have an impact on reducing delayed diagnosis of pulmonary fibrosis.</p><p>NHS England is responsible for the commissioning of services for interstitial lung disease and funds the cost of anti-fibrotic treatments to treat this disease. Access to these treatments has recently been expanded to patients with non-idiopathic pulmonary fibrosis following the publication of the National Institute for Health and Care Excellence’s technology appraisal ‘Nintedanib for treating progressive fibrosing interstitial lung diseases’ in November 2021. <br> This is available at the following link:<br> <br> <a href="https://www.nice.org.uk/guidance/ta747" target="_blank">https://www.nice.org.uk/guidance/ta747</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 16:54:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4831 label Biography information for Ian Byrne

1669492

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the level of supplies of ADHD medication for (a) children and (b) adults.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	1646
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>We are aware of disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD). While some issues have now been resolved, we know that there are currently disruptions to the supply of some other medicines, primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. These issues are expected to resolve in early 2024.</p><p> </p><p>We understand how frustrating and distressing medicine shortages can be and we want to assure patients that we are working intensively with the respective manufacturers to resolve the issues as soon as possible and to ensure patients have continuous access to ADHD medicines in the United Kingdom, in the short and long term.</p><p> </p><p>We have issued communications to the National Health Service to advise healthcare professionals on management of patients whilst there continue to be disruptions to supplies. Patients are advised to speak to their clinician regarding any concerns they have and to discuss the suitability of treatment with alternative medicines.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:12:03 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4491 label Biography information for Vicky Foxcroft

1669501

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Abiraterone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to take steps to increase access to Abiraterone.
tabling member constituency	The Wrekin
tabling member printed	Mark Pritchard
uin	1504
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new licensed medicines represent a clinically and cost-effective use of resources. The NHS is legally required to fund medicines recommended by NICE, usually within three months of final guidance.</p><p> </p><p>NICE has published guidance recommending abiraterone for the treatment of metastatic hormone-relapsed prostate cancer before chemotherapy is indicated and for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen. NHS England funds abiraterone for these indications of prostate cancer in line with NICE’s recommendations, making it routinely available for the treatment of eligible patients.</p><p> </p><p>Abiraterone is not licensed for the treatment of non-metastatic prostate cancer and has therefore not been appraised by NICE for such use. NHS England is currently considering a clinical policy proposal for abiraterone as a treatment option for patients newly diagnosed with high risk, non-metastatic, hormone-sensitive prostate cancer, or in whom prostate cancer has relapsed after at least 12 months without treatment. This specific policy proposal is due to be discussed later this month, and if supported by a clinical panel it will progress to stakeholder testing by January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 16:58:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1576 label Biography information for Mark Pritchard

1669538

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cardiovascular Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to publish the findings of the Government Champion for Personalised Prevention's taskforce on cardiovascular disease.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	1604
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The Government is considering the recommendations of the Government Champion for Personalised Prevention. There are currently no plans to publish his report.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:00:56 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1669540

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to increase the specialist cardiology workforce in (a) primary and (b) secondary care.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	1606
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>There are currently 3,738 full time equivalent doctors working in the specialty of cardiology in the National Health Service in England. This is 666 (21.7%) more than in 2019. Within this there are 1,653 full time equivalent consultants working in the speciality of cardiology, 278 (20.2%) more than in 2019.</p><p> </p><p> </p><p>The NHS Long Term Workforce Plan (LTWP), published by NHS England on 30 June 2023, sets out our aim to double the number of medical school places in England to 15,000 places a year by 2031/32. It also sets out how we will work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29. The LTWP commits to an adequate growth in foundation placement capacity, as those taking up these new places begin to graduate, and a commensurate increase in specialty training places that meets the demands of the NHS in the future. This will substantially increase the potential pipeline for the cardiologist workforce in primary and secondary care.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:20:39 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1669548

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anaesthesia Associates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the impact of the number of anaesthesia associates on the quality of care.
tabling member constituency	Edmonton
tabling member printed	Kate Osamor
uin	1659
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The NHS Long Term Workforce Plan (LTWP), which was published on 30 June 2023, sets out an expansion of new and extended roles to increase the breadth of skills within multidisciplinary teams, better meet the needs of patients, their families and unpaid carers, and enable more care to be delivered in primary and community settings. The National Health Service is determined to continue to invest in training opportunities and the development of career paths for the whole workforce. The LTWP set out that training places for anaesthesia associates (AAs) will increase to 250 by 2028/29. This will support our ambition to increase places to 280 a year by 2031/32.</p><p>We strongly recommend that employers only consider recruiting AAs who are on the AA Managed Voluntary Register (MVR) which is currently held by the Royal College of Anaesthetists (RCoA). It enables supervisors and employers to check whether an individual is qualified and safe to work in the United Kingdom.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:25:16 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4515 label Biography information for Kate Osamor

1669621

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate she has made of the volume of medication prescribed to treat ADHD in each year since 2010.
tabling member constituency	Lewisham East
tabling member printed	Janet Daby
uin	1711
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The information is not held in the requested format. Data relating to the clinical indication for which a prescription is intended is not captured; some items dispensed can be used for a variety of clinical indications.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 16:53:41 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4698 label Biography information for Janet Daby

1669674

registered interest
date	13/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Psilocybin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to provide access to psilocybin for the treatment of (a) severe depression and (b) other health conditions.
tabling member constituency	Bishop Auckland
tabling member printed	Dehenna Davison
uin	1758
answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR), who have invested £1.1 million in a randomised controlled trial to examine if it is feasible, safe and effective to use psilocybin to treat people with treatment-resistant depression. The NIHR is supporting psilocybin research via the NIHR King’s Clinical Research Facility and the NIHR Maudsley Biomedical Research Centre, where researchers are developing and evaluating the efficacy and safety of psilocybin therapy for use in the National Health Service and other healthcare settings. The NIHR welcomes funding applications for research into any aspect of human health, including the use of psilocybin in the treatment of severe depression and other chronic conditions.</p><p>Before any new medicine can be used to treat patients, it must go through a strictly monitored development process. Manufacturers of medicines are expected to conduct research and clinical trials, and medicines must undergo scrutiny by the Medicines and Healthcare Products Regulatory Agency which will assess the safety, quality and efficacy of a product before a marketing authorisation (licence) may be granted. For a licence to be granted for a medicine the MHRA must receive a full marketing application from the applicant. In addition, the National Institute for Health and Care Excellence (NICE) evaluates all new medicines for clinical and cost effectiveness and makes recommendations about routine funding and use on the NHS. This is the foundation of NHS decisions about routine access and funding of medicines.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:19:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4737 label Biography information for Dehenna Davison